Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2668268rdf:typepubmed:Citationlld:pubmed
pubmed-article:2668268lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:2668268lifeskim:mentionsumls-concept:C0038615lld:lifeskim
pubmed-article:2668268lifeskim:mentionsumls-concept:C0016213lld:lifeskim
pubmed-article:2668268lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:2668268lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:2668268lifeskim:mentionsumls-concept:C1145667lld:lifeskim
pubmed-article:2668268lifeskim:mentionsumls-concept:C2825311lld:lifeskim
pubmed-article:2668268lifeskim:mentionsumls-concept:C2349209lld:lifeskim
pubmed-article:2668268pubmed:issue23lld:pubmed
pubmed-article:2668268pubmed:dateCreated1989-9-11lld:pubmed
pubmed-article:2668268pubmed:abstractTextMenaquinol-fumarate oxidoreductase of Escherichia coli is a four-subunit membrane-bound complex that catalyzes the final step in anaerobic respiration when fumarate is the terminal electron acceptor. The catalytic domain of fumarate reductase consists of the FrdA subunit, which contains the active site, and a FAD prosthetic group covalently attached to His44, plus the FrdB subunit which contains at least two of the three nonidentical iron-sulfur clusters of the enzyme. To examine the role of covalently bound FAD in enzyme activity and electron transfer during anaerobic cell growth, site-directed mutagenesis was used to alter His44 of the FrdA subunit to a Ser, Cys, or Tyr residue. The resulting mutant enzyme complexes that were synthesized associated normally with the cytoplasmic membrane, but had decreased ability (greater than 70%) to reduce fumarate with reduced benzyl viologen, an artificial electron donor of low redox potential (Em = -359 mV; Clark, W. M. (1972) Oxidation-Reduction Potentials of Organic Systems, Robert E. Kreiger Publishing Co., Melbourne, FL). Even lower activities were measured when the higher potential, natural electron donor menaquinol was used, which, however, correlated with the slower growth rates of the different mutant complexes. In contrast to the normal enzyme, the mutant enzyme complexes were unable to oxidize succinate. Substitution of Arg for His44 produced a totally inactive enzyme complex that permitted no cell growth on nonfermentable substrates with fumarate as electron acceptor. All four mutant complexes contained noncovalently bound FAD in stoichiometric amounts. These data indicate a unique role of the 8 alpha-[N(3)-histidyl] FAD linkage in enzyme activity, by raising the redox potential of free FAD to permit reduction by both menaquinol and succinate.lld:pubmed
pubmed-article:2668268pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2668268pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2668268pubmed:languageenglld:pubmed
pubmed-article:2668268pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2668268pubmed:citationSubsetIMlld:pubmed
pubmed-article:2668268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2668268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2668268pubmed:statusMEDLINElld:pubmed
pubmed-article:2668268pubmed:monthAuglld:pubmed
pubmed-article:2668268pubmed:issn0021-9258lld:pubmed
pubmed-article:2668268pubmed:authorpubmed-author:AckrellB ABAlld:pubmed
pubmed-article:2668268pubmed:authorpubmed-author:CecchiniGGlld:pubmed
pubmed-article:2668268pubmed:authorpubmed-author:GunsalusR PRPlld:pubmed
pubmed-article:2668268pubmed:authorpubmed-author:WhittakerKKlld:pubmed
pubmed-article:2668268pubmed:authorpubmed-author:BlautMMlld:pubmed
pubmed-article:2668268pubmed:authorpubmed-author:ValdovinosAAlld:pubmed
pubmed-article:2668268pubmed:issnTypePrintlld:pubmed
pubmed-article:2668268pubmed:day15lld:pubmed
pubmed-article:2668268pubmed:volume264lld:pubmed
pubmed-article:2668268pubmed:ownerNLMlld:pubmed
pubmed-article:2668268pubmed:authorsCompleteYlld:pubmed
pubmed-article:2668268pubmed:pagination13599-604lld:pubmed
pubmed-article:2668268pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2668268pubmed:meshHeadingpubmed-meshheading:2668268-...lld:pubmed
pubmed-article:2668268pubmed:meshHeadingpubmed-meshheading:2668268-...lld:pubmed
pubmed-article:2668268pubmed:meshHeadingpubmed-meshheading:2668268-...lld:pubmed
pubmed-article:2668268pubmed:meshHeadingpubmed-meshheading:2668268-...lld:pubmed
pubmed-article:2668268pubmed:meshHeadingpubmed-meshheading:2668268-...lld:pubmed
pubmed-article:2668268pubmed:meshHeadingpubmed-meshheading:2668268-...lld:pubmed
pubmed-article:2668268pubmed:meshHeadingpubmed-meshheading:2668268-...lld:pubmed
pubmed-article:2668268pubmed:meshHeadingpubmed-meshheading:2668268-...lld:pubmed
pubmed-article:2668268pubmed:meshHeadingpubmed-meshheading:2668268-...lld:pubmed
pubmed-article:2668268pubmed:year1989lld:pubmed
pubmed-article:2668268pubmed:articleTitleFumarate reductase mutants of Escherichia coli that lack covalently bound flavin.lld:pubmed
pubmed-article:2668268pubmed:affiliationDepartment of Microbiology, University of California, Los Angeles 90024.lld:pubmed
pubmed-article:2668268pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2668268pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2668268pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:2668268pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:948667entrezgene:pubmedpubmed-article:2668268lld:entrezgene
entrez-gene:948453entrezgene:pubmedpubmed-article:2668268lld:entrezgene
entrez-gene:948454entrezgene:pubmedpubmed-article:2668268lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2668268lld:pubmed